Endogenous Human Proteins Interfering with Amyloid Formation
- PMID: 35327638
- PMCID: PMC8946693
- DOI: 10.3390/biom12030446
Endogenous Human Proteins Interfering with Amyloid Formation
Abstract
Amyloid formation is a pathological process associated with a wide range of degenerative disorders, including Alzheimer's disease, Parkinson's disease, and diabetes mellitus type 2. During disease progression, abnormal accumulation and deposition of proteinaceous material are accompanied by tissue degradation, inflammation, and dysfunction. Agents that can interfere with the process of amyloid formation or target already formed amyloid assemblies are consequently of therapeutic interest. In this context, a few endogenous proteins have been associated with an anti-amyloidogenic activity. Here, we review the properties of transthyretin, apolipoprotein E, clusterin, and BRICHOS protein domain which all effectively interfere with amyloid in vitro, as well as displaying a clinical impact in humans or animal models. Their involvement in the amyloid formation process is discussed, which may aid and inspire new strategies for therapeutic interventions.
Keywords: BRICHOS; IAPP; alpha-synuclein; amyloid inhibition; amyloid-beta; apolipoprotein E; clusterin; endogenous proteins; transthyretin.
Conflict of interest statement
The authors declare no conflict of interest.
Figures









Similar articles
-
Cross-talk between amyloidogenic proteins in type-2 diabetes and Parkinson's disease.Proc Natl Acad Sci U S A. 2016 Nov 1;113(44):12473-12477. doi: 10.1073/pnas.1610371113. Epub 2016 Oct 17. Proc Natl Acad Sci U S A. 2016. PMID: 27791129 Free PMC article.
-
Crosstalk Between Alpha-Synuclein and Other Human and Non-Human Amyloidogenic Proteins: Consequences for Amyloid Formation in Parkinson's Disease.J Parkinsons Dis. 2020;10(3):819-830. doi: 10.3233/JPD-202085. J Parkinsons Dis. 2020. PMID: 32538869 Free PMC article. Review.
-
The Strategies of Development of New Non-Toxic Inhibitors of Amyloid Formation.Int J Mol Sci. 2023 Feb 14;24(4):3781. doi: 10.3390/ijms24043781. Int J Mol Sci. 2023. PMID: 36835194 Free PMC article. Review.
-
Interaction of amyloidogenic proteins in pancreatic β cells from subjects with synucleinopathies.Acta Neuropathol. 2018 Jun;135(6):877-886. doi: 10.1007/s00401-018-1832-0. Epub 2018 Mar 13. Acta Neuropathol. 2018. PMID: 29536165
-
Sequence and structure-based peptides as potent amyloid inhibitors: A review.Arch Biochem Biophys. 2020 Nov 30;695:108614. doi: 10.1016/j.abb.2020.108614. Epub 2020 Sep 30. Arch Biochem Biophys. 2020. PMID: 33010227 Review.
Cited by
-
Molecular modeling of apoE in complexes with Alzheimer's amyloid-β fibrils from human brain suggests a structural basis for apolipoprotein co-deposition with amyloids.Cell Mol Life Sci. 2023 Nov 27;80(12):376. doi: 10.1007/s00018-023-05026-w. Cell Mol Life Sci. 2023. PMID: 38010414 Free PMC article.
-
CoPPIs algorithm: a tool to unravel protein cooperative strategies in pathophysiological conditions.Brief Bioinform. 2025 Mar 4;26(2):bbaf146. doi: 10.1093/bib/bbaf146. Brief Bioinform. 2025. PMID: 40194557 Free PMC article.
-
Extracellular chaperone networks and the export of J-domain proteins.J Biol Chem. 2023 Feb;299(2):102840. doi: 10.1016/j.jbc.2022.102840. Epub 2022 Dec 26. J Biol Chem. 2023. PMID: 36581212 Free PMC article. Review.
-
Roles of Tryptophan and Charged Residues on the Polymorphisms of Amyloids Formed by K-Peptides of Hen Egg White Lysozyme Investigated through Molecular Dynamics Simulations.Int J Mol Sci. 2023 Jan 30;24(3):2626. doi: 10.3390/ijms24032626. Int J Mol Sci. 2023. PMID: 36768943 Free PMC article.
-
OAF: a new member of the BRICHOS family.Bioinform Adv. 2022 Nov 24;2(1):vbac087. doi: 10.1093/bioadv/vbac087. eCollection 2022. Bioinform Adv. 2022. PMID: 36699367 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials